Clinical Trials Browser

OTHER × Head and Neck Neoplasms × Ipilimumab × Clear all

NCT02919683 2026-01-28

Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity

Phase 2 Active not recruiting

30 enrolled 14 charts

Head and Neck Neoplasms

NCT04954599 2025-10-07

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Phase 1/2 Recruiting

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT02812524 2025-03-10

Ipilimumab for Head and Neck Cancer Patients

Phase 1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03003637 2023-10-23

IMCISION

Phase 1/2 Completed

Head and Neck Neoplasms

NCT03700905 2023-05-23

IMSTAR-HN

Phase 3 Unknown

Head and Neck Neoplasms